VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator Gallery VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator By Chloe Atkinson|2024-05-16T22:59:17+00:00June 30th, 2022|Uncategorized| Read More
VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production Gallery VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production By Chloe Atkinson|2024-05-16T23:00:54+00:00March 5th, 2022|Uncategorized| Read More
VasoDynamics strengthens Board and management team with key appointments Gallery VasoDynamics strengthens Board and management team with key appointments By Chloe Atkinson|2024-05-16T23:01:01+00:00January 10th, 2022|Uncategorized| Read More
VasoDynamics attracts £1.9m from new investors Gallery VasoDynamics attracts £1.9m from new investors By Chloe Atkinson|2024-05-16T23:01:06+00:00November 30th, 2021|Uncategorized| Read More
VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development Gallery VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development By Chloe Atkinson|2024-05-16T23:00:21+00:00September 21st, 2021|Uncategorized| Read More
VasoDynamics appoints Gill Jennings & Every LLP of London. Gallery VasoDynamics appoints Gill Jennings & Every LLP of London. By Chloe Atkinson|2024-05-16T23:00:16+00:00June 29th, 2021|Uncategorized| Read More
VasoDynamics becomes a member of UK BioIndustry Association (BIA) and attends the BIA Start-up Festival virtual event on 19th May 2021. Gallery VasoDynamics becomes a member of UK BioIndustry Association (BIA) and attends the BIA Start-up Festival virtual event on 19th May 2021. By Chloe Atkinson|2024-05-16T23:00:10+00:00May 19th, 2021|Uncategorized| Read More